+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Prognostic value of prognostic nutritional index and systemic immune-inflammation index in patients with osteosarcoma



Prognostic value of prognostic nutritional index and systemic immune-inflammation index in patients with osteosarcoma



Journal of Cellular Physiology 2019



The aim of this study was to evaluate the relationship between prognostic nutritional index (PNI) and systemic immune-inflammation index (SII) and clinical features and prognosis of osteosarcoma patients. We retrospectively investigated 126 patients with surgery for osteosarcoma between 2012 and 2018 at our hospital. The preoperative PNI was calculated as albumin level (g/L) + 5 × total lymphocyte count (10 9 /L). The SII was defined as platelet × neutrophil/lymphocyte counts. The optimal cut-off values for PNI and SII were evaluated with receiver operating curve analysis. Clinical features and PNI and SII were tested with the χ 2 test. The effects of PNI and SII on overall survival (OS) was investigated by Kaplan-Meier method and Cox proportional hazards model. A low preoperative PNI was remarkably correlated with tumor size, Enneking stage, pathological fracture, local recurrence, metastasis, and neoadjuvant chemotherapy ( p < 0.05). Whereas, a high SII was significantly associated with tumor size, histological type, Enneking stage, and neoadjuvant chemotherapy ( p < 0.05). There was a significant negative relationship between the PNI and SII ( r = 0.384; p < 0.001). For univariate analyses, the results revealed that tumor size, local recurrence, metastasis, PNI, and SII were predictors of OS ( p < 0.05). In multivariate analyses, local recurrence ( p = 0.010), metastasis ( p < 0.001), PNI ( p < 0.001), and SII ( p = 0.029) as independent prognostic factors were significantly correlated with OS. This study suggested that PNI and SII could be important prognostic parameters for patients with osteosarcoma.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 066607797

Download citation: RISBibTeXText

PMID: 30891768

DOI: 10.1002/jcp.28476


Related references

The predictive value of a preoperative systemic immune-inflammation index and prognostic nutritional index in patients with esophageal squamous cell carcinoma. Journal of Cellular Physiology 234(2): 1794-1802, 2018

Prognostic value of systemic immune-inflammation index in patients with gastric cancer. Chinese Journal of Cancer 36(1): 75, 2018

The Prognostic Nutritional Index and Nutritional Risk Index Are Associated with Disease Activity in Patients with Systemic Lupus Erythematosus. Nutrients 11(3), 2019

Prognostic value of pretreatment systemic immune-inflammation index in patients with gastrointestinal cancers. Journal of Cellular Physiology 2018, 2018

Inflammation-based prognostic scores and nutritional prognostic index in patients with locally-advanced unresectable colorectal cancer. World Journal of Surgical Oncology 12: 210, 2015

Systemic immune-inflammation index (SII) is a useful prognostic indicator for patients with squamous cell carcinoma of the esophagus. Medicine 96(4): E5886, 2017

Prognostic value of systemic immune-inflammation index in patients with advanced non-small-cell lung cancer. Future Oncology 14(25): 2643-2650, 2018

A novel inflammation-based prognostic score for patients with esophageal squamous cell carcinoma: the c-reactive protein/prognostic nutritional index ratio. Oncotarget 7(38): 62123-62132, 2016

No Difference of the Systemic Immune-Inflammation Index as Prognostic Factor for Patients with Adenocarcinoma of the Gastroesophageal Junction With or Without Neoadjuvant Treatment. Journal of the American College of Surgeons 227(4): S245-S246, 2018

Prognostic value of preoperative neutrophil to lymphocyte ratio is superior to systemic immune inflammation index for survival in patients with Glioblastoma. Clinical Neurology and Neurosurgery 181: 24-27, 2019

Systemic immune-inflammation index as a useful prognostic indicator predicts survival in patients with advanced gastric cancer treated with neoadjuvant chemotherapy. Cancer Management and Research 9: 849-867, 2017

Prognostic value of Systemic immune-inflammation index in cancer: A meta-analysis. Journal of Cancer 9(18): 3295-3302, 2018

Combination of the Preoperative Systemic Immune-Inflammation Index and Monocyte-Lymphocyte Ratio as a Novel Prognostic Factor in Patients with Upper-Tract Urothelial Carcinoma. Annals of Surgical Oncology 2018, 2018

The Prognostic Value of aspartate aminotransferase to lymphocyte ratio and systemic immune-inflammation index for Overall Survival of Hepatocellular Carcinoma Patients Treated with palliative Treatments. Journal of Cancer 10(10): 2299-2311, 2019

Prognostic significance of systemic immune-inflammation index in triple-negative breast cancer. Cancer Management and Research Volume 11: 4471-4480, 2019